Novo Integrated Sciences Total Liabilities 2012-2024 | NVOS

Novo Integrated Sciences total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Novo Integrated Sciences Annual Total Liabilities
(Millions of US $)
2024 $18
2023 $11
2022 $19
2021 $18
2020 $6
2019 $7
2018 $5
2017 $10
2016 $0
2016 $10
2015 $0
2014 $1
2013 $1
2012 $1
2012 $
2011 $2
2011 $
Novo Integrated Sciences Quarterly Total Liabilities
(Millions of US $)
2024-08-31 $18
2024-05-31 $26
2024-02-29 $13
2023-11-30 $14
2023-08-31 $11
2023-05-31 $9
2023-02-28 $10
2022-11-30 $17
2022-08-31 $19
2022-05-31 $27
2022-02-28 $26
2021-11-30 $20
2021-08-31 $18
2021-05-31 $6
2021-02-28 $6
2020-11-30 $6
2020-08-31 $6
2020-05-31 $6
2020-02-29 $6
2019-11-30 $7
2019-08-31 $7
2019-05-31 $6
2019-02-28 $4
2018-11-30 $5
2018-08-31 $5
2018-05-31 $5
2018-02-28 $5
2017-11-30 $9
2017-08-31 $10
2017-05-31 $10
2017-03-31 $0
2017-02-28
2016-12-31
2016-11-30
2016-09-30 $0
2016-06-30 $0
2016-05-31
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-08-31
2012-06-30 $1
2012-03-31 $2
2012-02-29
2011-12-31 $2
2011-11-30
2011-09-30
2011-08-31 $0
2011-06-30
2011-05-31 $0
2011-03-31
2011-02-28 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.002B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.128B 0.00
Quest Diagnostics (DGX) United States $16.942B 17.17
DaVita (DVA) United States $12.579B 16.27
Encompass Health (EHC) United States $9.173B 21.63
Chemed (CHE) United States $7.854B 24.14
Elanco Animal Health (ELAN) United States $5.650B 13.45
RadNet (RDNT) United States $5.092B 112.75
Option Care Health (OPCH) United States $4.083B 19.35
Amedisys (AMED) United States $3.010B 21.42
LifeStance Health (LFST) United States $2.958B 0.00
Addus HomeCare (ADUS) United States $2.273B 26.67
Astrana Health (ASTH) United States $1.658B 22.68
U.S Physical Therapy (USPH) United States $1.313B 34.52
Pennant (PNTG) United States $0.887B 35.86
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Daxor (DXR) United States $0.040B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00